News
News Center
Bairui granules and other innovative medicines made a brilliant debut in the national "13th five year plan" scientific and technological innovation achievement exhibition
Release time:
2021-10-27 15:42
Source:
With the theme of "innovation driven development towards a strong scientific and technological country", the exhibition focuses on the major scientific and technological achievements made in national scientific and technological innovation since the 13th five year plan. Li Keqiang, Li Zhanshu, Wang Yang, Wang Huning, zhaoleji and Han Zheng, members of the Standing Committee of the Political Bureau of the CPC Central Committee, and vice president Wang Qishan also visited the exhibition.
Photographed by Xinhua News Agency reporter xiehuanchi
For people's life and health, the exhibition focuses on the latest achievements such as "scientific and technological anti epidemic", heavy new drugs that benefit people's livelihood and integrated whole-body positron emission / magnetic resonance imaging equipment... Xijinping watched carefully, listened carefully to the explanations of the staff and asked about the situation.
Among them, two self-developed drugs of Jiuhua Huayuan Pharmaceutical, Bairui granule and Yuye Jinhua Qingre tablet, appeared in the "major special" exhibition area as one of the few innovative traditional Chinese medicine drugs. Yuye Jinhua Qingre tablet is a heavy listed product of Jiuhua Huayuan Pharmaceutical Co., Ltd. in 2021. It is a 6-category innovative Chinese medicine refined by Guangxi Zhuang medicine Yuye Jinhua after 10 years of research by chunzhengtang, a subsidiary of Jiuhua Huayuan Pharmaceutical Co., Ltd. and has a special effect on pharyngitis. As a major special scientific and technological achievement of "major new drug creation", Bairui granule participated in the exhibition, which fully reflected the state's affirmation and encouragement of Bairui granule in the research and development of traditional Chinese medicine and its clinical role.
玉叶金花清热片原料药——玉叶金花标本 （左） 百蕊颗粒原料药——百蕊草标本 （右）
During the 13th Five Year Plan period, the national new drug program has successfully developed 72 class 1 innovative drugs and 36 traditional Chinese medicine innovative drugs. Relying on the platform established with special support, effective "three drugs and three parties" have been selected, which has contributed China's strength to the global anti epidemic. As a star product in the field of upper respiratory tract infection, bailui granule also played a positive role in the prevention and treatment of respiratory tract infections during the epidemic.
Photographed by Xinhua News Agency reporter lixueren
Innovation is the soul of a nation's progress, the inexhaustible source of a country's prosperity, and the source power for the sustainable development of enterprises. Since its establishment in 2004, Jiuhua Huayuan Pharmaceutical has adhered to technical cooperation with advanced scientific research institutions at home and abroad to create an international level independent innovation drug R & D engine for the rapid development of scientific and technological innovation. Through years of continuous persistence, business innovation, scientific and technological innovation and marketing innovation, the enterprise has developed into a leading enterprise in the specialized subdivision field and a leading enterprise in natural medicine and botanical medicine. We will continue to take people's health as the foundation, independent innovation as the driving force, and national strength as the support, accelerate the comprehensive improvement of Jiuhua Huayuan Pharmaceutical's pharmaceutical innovation ability, and create more new drug achievements that benefit thousands of people.
Related News
